Linear Clinical Research

Perth, Western Australia WA 6009

7 studies enrolling now · 15 studies all time

What they study most

Advanced Malignancies, Advanced or Metastatic Solid Tumors, Angioimmunoblastic T-cell Lymphoma, Atopic Dermatitis, B-cell Lymphoma, B-cell Non-Hodgkin Lymphoma, Cervical Cancer, Chronic Obstructive Pulmonary Disease, Colorectal Cancer (CRC), Dedifferentiated Liposarcoma, Diffuse Large B Cell Lymphoma, Dyslipidemias

Studies at this site

• IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas — Recruiting now
• TLN-372 in Advanced KRAS Mutant Solid Tumors — Recruiting now
• TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas — Recruiting now
• A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) — Recruiting now
• A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP) — Recruiting now
• A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors — Recruiting now
• A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments — Recruiting now
• Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma — Recruiting now
• CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. — Recruiting now
• A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors — Running, not enrolling
• A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors — Running, not enrolling
• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies — Completed
• Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a) — Completed
• Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical) — Completed
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis — Completed